MT-105

N/A

Report date: 2023/09/25 11:41:30
NME

Base Information

Drug NameMT-105
Drug Alias NameMT-105
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-4/beta-7 antagonists
TargetsIntegrin alpha-4/beta-7
Therapy Area/IndicationsColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMorphic Therapeutic Inc
China Registration ClassN/A

Develop Information

Active CompaniesMorphic Therapeutic Inc
Inactive CompaniesN/A
Active IndicationsColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A